APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Pain Management Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Human Pain Management Drug Industry Research Report 2026

22 December 2025146 pages

Choose your research edition.

Industry ResearchHuman Pain Management Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Pain Management Drug Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Human Pain Management Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Pain Management Drug Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Pain Management Drug Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Human Pain Management Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Human Pain Management Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Human Pain Management Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Human Pain Management Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Human Pain Management Drug include Teva Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Novartis AG, Pfizer Inc., GSK plc., Bayer AG and Bristol Myers Squibb Co., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Human Pain Management Drug market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Human Pain Management Drug.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Pain Management Drug Market by Company

Teva Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Sanofi S.A.

Johnson & Johnson (Janssen Pharmaceuticals, Inc.)

Novartis AG

Pfizer Inc.

GSK plc.

Bayer AG

Bristol Myers Squibb Co.

AbbVie Inc. (Allergan plc)

AstraZeneca

Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)

Viatris

Purdue Pharmaceuticals L.P.

Procter & Gamble

Perrigo Company Plc.

Mallinckrodt Pharmaceuticals

F. Hoffmann-La Roche Ltd.

Endo Pharmaceuticals Inc.

Cardinal Health

Boehringer Ingelheim International GmbH

Bausch Health Companies Inc.

Amneal Pharmaceuticals

Abbott Laboratories, Inc.

Human Pain Management Drug Segment by Type

OTC

Rx

Human Pain Management Drug Segment by Application

Hospital

Retail Pharmacy

Other

Human Pain Management Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Pain Management Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Pain Management Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Pain Management Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Human Pain Management Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Pain Management Drug Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Human Pain Management Drug Revenue Market Share by Type (2021-2026) Table 7. Global Human Pain Management Drug Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Human Pain Management Drug Revenue Market Share by Type (2027-2032) Table 9. Global Human Pain Management Drug Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Human Pain Management Drug Revenue Market Share by Application (2021-2026) Table 11. Global Human Pain Management Drug Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Human Pain Management Drug Revenue Market Share by Application (2027-2032) Table 13. Global Human Pain Management Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Human Pain Management Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Human Pain Management Drug Market Share by Region (2021-2026) Table 16. Global Human Pain Management Drug Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Human Pain Management Drug Market Share by Region (2027-2032) Table 18. Human Pain Management Drug Industry Trends Table 19. Human Pain Management Drug Industry Drivers Table 20. Human Pain Management Drug Industry Opportunities and Challenges Table 21. Human Pain Management Drug Market Restraints Table 22. Global Top Human Pain Management Drug Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Human Pain Management Drug Revenue Market Share by Players (2021-2026) Table 24. Global Human Pain Management Drug Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Human Pain Management Drug, Headquarters and Area Served Table 26. Global Human Pain Management Drug Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Human Pain Management Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Human Pain Management Drug Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Human Pain Management Drug Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Human Pain Management Drug Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Human Pain Management Drug Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Human Pain Management Drug Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Human Pain Management Drug Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Human Pain Management Drug Market Size by Country (2027-2032) & (US$ Million) Table 45. Teva Pharmaceuticals Ltd. Company Information Table 46. Teva Pharmaceuticals Ltd. Business Overview Table 47. Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 48. Teva Pharmaceuticals Ltd. Human Pain Management Drug Product Portfolio Table 49. Teva Pharmaceuticals Ltd. Recent Developments Table 50. Sun Pharmaceutical Industries Ltd. Company Information Table 51. Sun Pharmaceutical Industries Ltd. Business Overview Table 52. Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 53. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product Portfolio Table 54. Sun Pharmaceutical Industries Ltd. Recent Developments Table 55. Sanofi S.A. Company Information Table 56. Sanofi S.A. Business Overview Table 57. Sanofi S.A. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 58. Sanofi S.A. Human Pain Management Drug Product Portfolio Table 59. Sanofi S.A. Recent Developments Table 60. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information Table 61. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview Table 62. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 63. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product Portfolio Table 64. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments Table 65. Novartis AG Company Information Table 66. Novartis AG Business Overview Table 67. Novartis AG Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 68. Novartis AG Human Pain Management Drug Product Portfolio Table 69. Novartis AG Recent Developments Table 70. Pfizer Inc. Company Information Table 71. Pfizer Inc. Business Overview Table 72. Pfizer Inc. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 73. Pfizer Inc. Human Pain Management Drug Product Portfolio Table 74. Pfizer Inc. Recent Developments Table 75. GSK plc. Company Information Table 76. GSK plc. Business Overview Table 77. GSK plc. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 78. GSK plc. Human Pain Management Drug Product Portfolio Table 79. GSK plc. Recent Developments Table 80. Bayer AG Company Information Table 81. Bayer AG Business Overview Table 82. Bayer AG Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 83. Bayer AG Human Pain Management Drug Product Portfolio Table 84. Bayer AG Recent Developments Table 85. Bristol Myers Squibb Co. Company Information Table 86. Bristol Myers Squibb Co. Business Overview Table 87. Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 88. Bristol Myers Squibb Co. Human Pain Management Drug Product Portfolio Table 89. Bristol Myers Squibb Co. Recent Developments Table 90. AbbVie Inc. (Allergan plc) Company Information Table 91. AbbVie Inc. (Allergan plc) Business Overview Table 92. AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 93. AbbVie Inc. (Allergan plc) Human Pain Management Drug Product Portfolio Table 94. AbbVie Inc. (Allergan plc) Recent Developments Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 98. AstraZeneca Human Pain Management Drug Product Portfolio Table 99. AstraZeneca Recent Developments Table 100. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information Table 101. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview Table 102. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 103. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product Portfolio Table 104. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments Table 105. Viatris Company Information Table 106. Viatris Business Overview Table 107. Viatris Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 108. Viatris Human Pain Management Drug Product Portfolio Table 109. Viatris Recent Developments Table 110. Purdue Pharmaceuticals L.P. Company Information Table 111. Purdue Pharmaceuticals L.P. Business Overview Table 112. Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 113. Purdue Pharmaceuticals L.P. Human Pain Management Drug Product Portfolio Table 114. Purdue Pharmaceuticals L.P. Recent Developments Table 115. Procter & Gamble Company Information Table 116. Procter & Gamble Business Overview Table 117. Procter & Gamble Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 118. Procter & Gamble Human Pain Management Drug Product Portfolio Table 119. Procter & Gamble Recent Developments Table 120. Perrigo Company Plc. Company Information Table 121. Perrigo Company Plc. Business Overview Table 122. Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 123. Perrigo Company Plc. Human Pain Management Drug Product Portfolio Table 124. Perrigo Company Plc. Recent Developments Table 125. Mallinckrodt Pharmaceuticals Company Information Table 126. Mallinckrodt Pharmaceuticals Business Overview Table 127. Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 128. Mallinckrodt Pharmaceuticals Human Pain Management Drug Product Portfolio Table 129. Mallinckrodt Pharmaceuticals Recent Developments Table 130. F. Hoffmann-La Roche Ltd. Company Information Table 131. F. Hoffmann-La Roche Ltd. Business Overview Table 132. F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 133. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product Portfolio Table 134. F. Hoffmann-La Roche Ltd. Recent Developments Table 135. Endo Pharmaceuticals Inc. Company Information Table 136. Endo Pharmaceuticals Inc. Business Overview Table 137. Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 138. Endo Pharmaceuticals Inc. Human Pain Management Drug Product Portfolio Table 139. Endo Pharmaceuticals Inc. Recent Developments Table 140. Cardinal Health Company Information Table 141. Cardinal Health Business Overview Table 142. Cardinal Health Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 143. Cardinal Health Human Pain Management Drug Product Portfolio Table 144. Cardinal Health Recent Developments Table 145. Boehringer Ingelheim International GmbH Company Information Table 146. Boehringer Ingelheim International GmbH Business Overview Table 147. Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 148. Boehringer Ingelheim International GmbH Human Pain Management Drug Product Portfolio Table 149. Boehringer Ingelheim International GmbH Recent Developments Table 150. Bausch Health Companies Inc. Company Information Table 151. Bausch Health Companies Inc. Business Overview Table 152. Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 153. Bausch Health Companies Inc. Human Pain Management Drug Product Portfolio Table 154. Bausch Health Companies Inc. Recent Developments Table 155. Amneal Pharmaceuticals Company Information Table 156. Amneal Pharmaceuticals Business Overview Table 157. Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 158. Amneal Pharmaceuticals Human Pain Management Drug Product Portfolio Table 159. Amneal Pharmaceuticals Recent Developments Table 160. Abbott Laboratories, Inc. Company Information Table 161. Abbott Laboratories, Inc. Business Overview Table 162. Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2021-2026) & (US$ Million) Table 163. Abbott Laboratories, Inc. Human Pain Management Drug Product Portfolio Table 164. Abbott Laboratories, Inc. Recent Developments Table 165. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Pain Management Drug Product Image Figure 5. Global Human Pain Management Drug Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Human Pain Management Drug Market Share by Type: 2025 VS 2032 Figure 7. OTC Product Figure 8. Rx Product Figure 9. Global Human Pain Management Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Human Pain Management Drug Market Share by Application: 2025 VS 2032 Figure 11. Hospital Product Figure 12. Retail Pharmacy Product Figure 13. Other Product Figure 14. Global Human Pain Management Drug Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Human Pain Management Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Human Pain Management Drug Market Share by Region: 2025 VS 2032 Figure 17. Global Human Pain Management Drug Market Share by Players in 2025 Figure 18. Global Human Pain Management Drug Manufacturers Established Date Figure 19. Global Top 5 and 10 Human Pain Management Drug Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Human Pain Management Drug Market Share by Country (2021-2032) Figure 23. United States Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Human Pain Management Drug Market Share by Country (2021-2032) Figure 26. Europe Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Human Pain Management Drug Market Share by Country (2021-2032) Figure 28. Germany Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Human Pain Management Drug Market Share by Country (2021-2032) Figure 38. China Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Human Pain Management Drug Market Share by Country (2021-2032) Figure 43. Australia Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Human Pain Management Drug Market Share by Country (2021-2032) Figure 48. Brazil Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Human Pain Management Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Teva Pharmaceuticals Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 54. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 55. Sanofi S.A. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 56. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 57. Novartis AG Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 58. Pfizer Inc. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 59. GSK plc. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 60. Bayer AG Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 61. Bristol Myers Squibb Co. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 62. AbbVie Inc. (Allergan plc) Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 63. AstraZeneca Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 64. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 65. Viatris Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 66. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 67. Procter & Gamble Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 68. Perrigo Company Plc. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 69. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 70. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 71. Endo Pharmaceuticals Inc. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 72. Cardinal Health Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 73. Boehringer Ingelheim International GmbH Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 74. Bausch Health Companies Inc. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 75. Amneal Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2021-2026) Figure 76. Abbott Laboratories, Inc. Revenue Growth Rate in Human Pain Management Drug Business (2021-2026)

Scope & coverage.

Types
  • OTC
  • Rx
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Teva Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
  • Novartis AG
  • Pfizer Inc.
  • GSK plc.
  • Bayer AG
  • Bristol Myers Squibb Co.
  • AbbVie Inc. (Allergan plc)
  • AstraZeneca
  • Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
  • Viatris
  • Purdue Pharmaceuticals L.P.
  • Procter & Gamble
  • Perrigo Company Plc.
  • Mallinckrodt Pharmaceuticals
  • F. Hoffmann-La Roche Ltd.
  • Endo Pharmaceuticals Inc.
  • Cardinal Health
  • Boehringer Ingelheim International GmbH
  • Bausch Health Companies Inc.
  • Amneal Pharmaceuticals
  • Abbott Laboratories, Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Human Pain Management Drug by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 OTC
  5. 2.2.3 Rx
  6. 2.3 Human Pain Management Drug by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospital
  9. 2.3.3 Retail Pharmacy
  10. 2.3.4 Other
  11. 2.4 Assumptions and Limitations
3 Human Pain Management Drug Breakdown Data by Type
  1. 3.1 Global Human Pain Management Drug Historic Market Size by Type (2021-2026)
  2. 3.2 Global Human Pain Management Drug Forecasted Market Size by Type (2027-2032)
4 Human Pain Management Drug Breakdown Data by Application
  1. 4.1 Global Human Pain Management Drug Historic Market Size by Application (2021-2026)
  2. 4.2 Global Human Pain Management Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Human Pain Management Drug Market Perspective (2021-2032)
  2. 5.2 Global Human Pain Management Drug Growth Trends by Region
  3. 5.2.1 Global Human Pain Management Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Human Pain Management Drug Historic Market Size by Region (2021-2026)
  5. 5.2.3 Human Pain Management Drug Forecasted Market Size by Region (2027-2032)
  6. 5.3 Human Pain Management Drug Market Dynamics
  7. 5.3.1 Human Pain Management Drug Industry Trends
  8. 5.3.2 Human Pain Management Drug Market Drivers
  9. 5.3.3 Human Pain Management Drug Market Challenges
  10. 5.3.4 Human Pain Management Drug Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Human Pain Management Drug Players by Revenue
  2. 6.1.1 Global Top Human Pain Management Drug Players by Revenue (2021-2026)
  3. 6.1.2 Global Human Pain Management Drug Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Human Pain Management Drug Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Human Pain Management Drug Head Office and Area Served
  6. 6.4 Global Human Pain Management Drug Players, Product Type & Application
  7. 6.5 Global Human Pain Management Drug Manufacturers Established Date
  8. 6.6 Global Human Pain Management Drug Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Human Pain Management Drug Market Size (2021-2032)
  2. 7.2 North America Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Human Pain Management Drug Market Size by Country (2021-2026)
  4. 7.4 North America Human Pain Management Drug Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Human Pain Management Drug Market Size (2021-2032)
  2. 8.2 Europe Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Human Pain Management Drug Market Size by Country (2021-2026)
  4. 8.4 Europe Human Pain Management Drug Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Human Pain Management Drug Market Size (2021-2032)
  2. 9.2 Asia-Pacific Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Human Pain Management Drug Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Human Pain Management Drug Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Human Pain Management Drug Market Size (2021-2032)
  2. 10.2 South America Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Human Pain Management Drug Market Size by Country (2021-2026)
  4. 10.4 South America Human Pain Management Drug Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Human Pain Management Drug Market Size (2021-2032)
  2. 11.2 Middle East & Africa Human Pain Management Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Human Pain Management Drug Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Human Pain Management Drug Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Teva Pharmaceuticals Ltd.
  2. 12.1.1 Teva Pharmaceuticals Ltd. Company Information
  3. 12.1.2 Teva Pharmaceuticals Ltd. Business Overview
  4. 12.1.3 Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2021-2026)
  5. 12.1.4 Teva Pharmaceuticals Ltd. Human Pain Management Drug Product Portfolio
  6. 12.1.5 Teva Pharmaceuticals Ltd. Recent Developments
  7. 12.2 Sun Pharmaceutical Industries Ltd.
  8. 12.2.1 Sun Pharmaceutical Industries Ltd. Company Information
  9. 12.2.2 Sun Pharmaceutical Industries Ltd. Business Overview
  10. 12.2.3 Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2021-2026)
  11. 12.2.4 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product Portfolio
  12. 12.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  13. 12.3 Sanofi S.A.
  14. 12.3.1 Sanofi S.A. Company Information
  15. 12.3.2 Sanofi S.A. Business Overview
  16. 12.3.3 Sanofi S.A. Revenue in Human Pain Management Drug Business (2021-2026)
  17. 12.3.4 Sanofi S.A. Human Pain Management Drug Product Portfolio
  18. 12.3.5 Sanofi S.A. Recent Developments
  19. 12.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
  20. 12.4.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information
  21. 12.4.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
  22. 12.4.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2021-2026)
  23. 12.4.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product Portfolio
  24. 12.4.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments
  25. 12.5 Novartis AG
  26. 12.5.1 Novartis AG Company Information
  27. 12.5.2 Novartis AG Business Overview
  28. 12.5.3 Novartis AG Revenue in Human Pain Management Drug Business (2021-2026)
  29. 12.5.4 Novartis AG Human Pain Management Drug Product Portfolio
  30. 12.5.5 Novartis AG Recent Developments
  31. 12.6 Pfizer Inc.
  32. 12.6.1 Pfizer Inc. Company Information
  33. 12.6.2 Pfizer Inc. Business Overview
  34. 12.6.3 Pfizer Inc. Revenue in Human Pain Management Drug Business (2021-2026)
  35. 12.6.4 Pfizer Inc. Human Pain Management Drug Product Portfolio
  36. 12.6.5 Pfizer Inc. Recent Developments
  37. 12.7 GSK plc.
  38. 12.7.1 GSK plc. Company Information
  39. 12.7.2 GSK plc. Business Overview
  40. 12.7.3 GSK plc. Revenue in Human Pain Management Drug Business (2021-2026)
  41. 12.7.4 GSK plc. Human Pain Management Drug Product Portfolio
  42. 12.7.5 GSK plc. Recent Developments
  43. 12.8 Bayer AG
  44. 12.8.1 Bayer AG Company Information
  45. 12.8.2 Bayer AG Business Overview
  46. 12.8.3 Bayer AG Revenue in Human Pain Management Drug Business (2021-2026)
  47. 12.8.4 Bayer AG Human Pain Management Drug Product Portfolio
  48. 12.8.5 Bayer AG Recent Developments
  49. 12.9 Bristol Myers Squibb Co.
  50. 12.9.1 Bristol Myers Squibb Co. Company Information
  51. 12.9.2 Bristol Myers Squibb Co. Business Overview
  52. 12.9.3 Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2021-2026)
  53. 12.9.4 Bristol Myers Squibb Co. Human Pain Management Drug Product Portfolio
  54. 12.9.5 Bristol Myers Squibb Co. Recent Developments
  55. 12.10 AbbVie Inc. (Allergan plc)
  56. 12.10.1 AbbVie Inc. (Allergan plc) Company Information
  57. 12.10.2 AbbVie Inc. (Allergan plc) Business Overview
  58. 12.10.3 AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2021-2026)
  59. 12.10.4 AbbVie Inc. (Allergan plc) Human Pain Management Drug Product Portfolio
  60. 12.10.5 AbbVie Inc. (Allergan plc) Recent Developments
  61. 12.11 AstraZeneca
  62. 12.11.1 AstraZeneca Company Information
  63. 12.11.2 AstraZeneca Business Overview
  64. 12.11.3 AstraZeneca Revenue in Human Pain Management Drug Business (2021-2026)
  65. 12.11.4 AstraZeneca Human Pain Management Drug Product Portfolio
  66. 12.11.5 AstraZeneca Recent Developments
  67. 12.12 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
  68. 12.12.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information
  69. 12.12.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
  70. 12.12.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2021-2026)
  71. 12.12.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product Portfolio
  72. 12.12.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments
  73. 12.13 Viatris
  74. 12.13.1 Viatris Company Information
  75. 12.13.2 Viatris Business Overview
  76. 12.13.3 Viatris Revenue in Human Pain Management Drug Business (2021-2026)
  77. 12.13.4 Viatris Human Pain Management Drug Product Portfolio
  78. 12.13.5 Viatris Recent Developments
  79. 12.14 Purdue Pharmaceuticals L.P.
  80. 12.14.1 Purdue Pharmaceuticals L.P. Company Information
  81. 12.14.2 Purdue Pharmaceuticals L.P. Business Overview
  82. 12.14.3 Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2021-2026)
  83. 12.14.4 Purdue Pharmaceuticals L.P. Human Pain Management Drug Product Portfolio
  84. 12.14.5 Purdue Pharmaceuticals L.P. Recent Developments
  85. 12.15 Procter & Gamble
  86. 12.15.1 Procter & Gamble Company Information
  87. 12.15.2 Procter & Gamble Business Overview
  88. 12.15.3 Procter & Gamble Revenue in Human Pain Management Drug Business (2021-2026)
  89. 12.15.4 Procter & Gamble Human Pain Management Drug Product Portfolio
  90. 12.15.5 Procter & Gamble Recent Developments
  91. 12.16 Perrigo Company Plc.
  92. 12.16.1 Perrigo Company Plc. Company Information
  93. 12.16.2 Perrigo Company Plc. Business Overview
  94. 12.16.3 Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2021-2026)
  95. 12.16.4 Perrigo Company Plc. Human Pain Management Drug Product Portfolio
  96. 12.16.5 Perrigo Company Plc. Recent Developments
  97. 12.17 Mallinckrodt Pharmaceuticals
  98. 12.17.1 Mallinckrodt Pharmaceuticals Company Information
  99. 12.17.2 Mallinckrodt Pharmaceuticals Business Overview
  100. 12.17.3 Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2021-2026)
  101. 12.17.4 Mallinckrodt Pharmaceuticals Human Pain Management Drug Product Portfolio
  102. 12.17.5 Mallinckrodt Pharmaceuticals Recent Developments
  103. 12.18 F. Hoffmann-La Roche Ltd.
  104. 12.18.1 F. Hoffmann-La Roche Ltd. Company Information
  105. 12.18.2 F. Hoffmann-La Roche Ltd. Business Overview
  106. 12.18.3 F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2021-2026)
  107. 12.18.4 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product Portfolio
  108. 12.18.5 F. Hoffmann-La Roche Ltd. Recent Developments
  109. 12.19 Endo Pharmaceuticals Inc.
  110. 12.19.1 Endo Pharmaceuticals Inc. Company Information
  111. 12.19.2 Endo Pharmaceuticals Inc. Business Overview
  112. 12.19.3 Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2021-2026)
  113. 12.19.4 Endo Pharmaceuticals Inc. Human Pain Management Drug Product Portfolio
  114. 12.19.5 Endo Pharmaceuticals Inc. Recent Developments
  115. 12.20 Cardinal Health
  116. 12.20.1 Cardinal Health Company Information
  117. 12.20.2 Cardinal Health Business Overview
  118. 12.20.3 Cardinal Health Revenue in Human Pain Management Drug Business (2021-2026)
  119. 12.20.4 Cardinal Health Human Pain Management Drug Product Portfolio
  120. 12.20.5 Cardinal Health Recent Developments
  121. 12.21 Boehringer Ingelheim International GmbH
  122. 12.21.1 Boehringer Ingelheim International GmbH Company Information
  123. 12.21.2 Boehringer Ingelheim International GmbH Business Overview
  124. 12.21.3 Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2021-2026)
  125. 12.21.4 Boehringer Ingelheim International GmbH Human Pain Management Drug Product Portfolio
  126. 12.21.5 Boehringer Ingelheim International GmbH Recent Developments
  127. 12.22 Bausch Health Companies Inc.
  128. 12.22.1 Bausch Health Companies Inc. Company Information
  129. 12.22.2 Bausch Health Companies Inc. Business Overview
  130. 12.22.3 Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2021-2026)
  131. 12.22.4 Bausch Health Companies Inc. Human Pain Management Drug Product Portfolio
  132. 12.22.5 Bausch Health Companies Inc. Recent Developments
  133. 12.23 Amneal Pharmaceuticals
  134. 12.23.1 Amneal Pharmaceuticals Company Information
  135. 12.23.2 Amneal Pharmaceuticals Business Overview
  136. 12.23.3 Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2021-2026)
  137. 12.23.4 Amneal Pharmaceuticals Human Pain Management Drug Product Portfolio
  138. 12.23.5 Amneal Pharmaceuticals Recent Developments
  139. 12.24 Abbott Laboratories, Inc.
  140. 12.24.1 Abbott Laboratories, Inc. Company Information
  141. 12.24.2 Abbott Laboratories, Inc. Business Overview
  142. 12.24.3 Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2021-2026)
  143. 12.24.4 Abbott Laboratories, Inc. Human Pain Management Drug Product Portfolio
  144. 12.24.5 Abbott Laboratories, Inc. Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst